Eurofins completes USD 400 million purchase of Element’s North American life sciences testing unit

• Eurofins completed the acquisition of Element Materials Technology’s Life Sciences Testing Services business in North America on Oct. 1, 2026.
• Deal value: USD 400 million enterprise value.
• Business runs 27 laboratories and facilities, employs about 750 staff, targets more than USD 150 million revenue in 2026.
• Operations will fold into Eurofins’ North American BioPharma and Life footprint, expanding coverage across the U.S. and Canada.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eurofins Scientific SE published the original content used to generate this news brief via Business Wire (Ref. ID: 20261001044310) on October 02, 2026, and is solely responsible for the information contained therein.